GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OTCPK:OASMY) » Definitions » Enterprise Value

Vivesto AB (Vivesto AB) Enterprise Value : $-2.93 Mil (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Vivesto AB Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vivesto AB's Enterprise Value is $-2.93 Mil. Vivesto AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-12.26 Mil. Therefore, Vivesto AB's EV-to-EBIT ratio for today is 0.24.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Vivesto AB's Enterprise Value is $-2.93 Mil. Vivesto AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-6.72 Mil. Therefore, Vivesto AB's EV-to-EBITDA ratio for today is 0.44.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Vivesto AB's Enterprise Value is $-2.93 Mil. Vivesto AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Vivesto AB's EV-to-Revenue ratio for today is .


Vivesto AB Enterprise Value Historical Data

The historical data trend for Vivesto AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivesto AB Enterprise Value Chart

Vivesto AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 213.03 290.28 112.25 9.11 -3.92

Vivesto AB Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.11 -1.66 -8.81 -6.98 -3.92

Competitive Comparison of Vivesto AB's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Vivesto AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivesto AB's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivesto AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Vivesto AB's Enterprise Value falls into.



Vivesto AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Vivesto AB's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Vivesto AB's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vivesto AB  (OTCPK:OASMY) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Vivesto AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-2.933/-12.262
=0.24

Vivesto AB's current Enterprise Value is $-2.93 Mil.
Vivesto AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.26 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Vivesto AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=-2.933/-6.72
=0.44

Vivesto AB's current Enterprise Value is $-2.93 Mil.
Vivesto AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.72 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Vivesto AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-2.933/0
=

Vivesto AB's current Enterprise Value is $-2.93 Mil.
Vivesto AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vivesto AB Enterprise Value Related Terms

Thank you for viewing the detailed overview of Vivesto AB's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivesto AB (Vivesto AB) Business Description

Traded in Other Exchanges
Address
Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.

Vivesto AB (Vivesto AB) Headlines

From GuruFocus